渗出性局限性脉络膜血管瘤的治疗:分次质子治疗(20 Gy 相对生物效应剂量,分8次)的疗效
回顾性分析43例渗出性且有症状的局限性脉络膜血管瘤患者,接受20 Gy相对生物效应剂量分8次质子束治疗。末次随访时全部患者超声肿瘤厚度消退,23/43(53.5%)达完全平坦瘢痕,除1例随访9个月者外视网膜均复位,37例(86%)视力改善或稳定,无放射性黄斑病变或视乳头病变。
要点
- 20 Gy相对生物效应剂量分8次质子治疗使全部43例肿瘤厚度消退,53.5%达完全平坦瘢痕。
- 除1例随访9个月者外视网膜均复位,86%患者视力改善或稳定。
- 无患者出现放射性黄斑病变或视乳头病变,但需更长随访确定远期放射后遗症。
核心结论
- 20 Gy相对生物效应剂量分8次质子束治疗可获得良好的解剖和功能结果,与相同剂量分4次的结果相当。
- 需要更长随访来确定远期放射后遗症。
研究设计与样本
- 回顾性综述2010年1月至2015年4月间治疗且随访至少6个月的患者。
- 共纳入43例渗出性且有症状的局限性脉络膜血管瘤患者。
主要发现
- 治疗前41例(95%)存在渗出性视网膜脱离,中位视力为20/63,中位肿瘤厚度为3.3 mm。
- 平均随访26个月(范围7-62个月)。
- 末次随访时全部患者超声肿瘤厚度消退,23/43(53.5%)达完全平坦瘢痕,达平坦瘢痕的平均时间为20个月。
- 除1例随访9个月者外视网膜均复位,37例(86%)视力改善或稳定,最终中位视力为20/25。
- 无患者出现放射性黄斑病变或视乳头病变。
局限性
- 需要更长随访来确定远期放射后遗症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate treatment of circumscribed choroidal hemangioma by hyperfractionated proton beam therapy protocol (20 gray relative biological effectiveness in 8 fractions) on tumor control, attachment of retina and visual function. METHODS: Retrospective review of patients treated between January 2010 and April 2015 with at least 6 months of follow-up. RESULTS: Forty-three patients with exudative and symptomatic circumscribed choroidal hemangioma were included. Before treatment, 41 (95%) presented an exudative retinal detachment, median visual acuity was 20/63 and median tumor thickness was 3.3 mm. Mean follow-up was 26 months (7-62). At last follow-up, all patients presented regression of ultrasound tumor thickness and 23/43 (53.5%) a totally flat scar. The mean time to achieve a flat scar was 20 months. Retina was reattached in all patients except one with 9 months of follow-up. Visual acuity was improved or stabilized in 37 patients (86%) and final median visual acuity was 20/25. No patient presented radiation maculopathy or papillopathy. CONCLUSION: Proton beam therapy with a dose of 20 gray relative biological effectiveness delivered in 8 fractions provides excellent anatomical and functional results and are comparable with those obtained with the same dose delivered in 4 fractions. Longer follow-up is required to determine the long-term radiation sequelae.
引用
- Mahdjoubi A, Dendale R, Desjardins L, et al. TREATMENT OF EXUDATIVE CIRCUMSCRIBED CHOROIDAL HEMANGIOMA: Efficacy of Fractionated Proton Therapy (20 Gray Relative Biological Effectiveness in 8 Fractions). Retina. 2019. PMID: 29252976. doi:10.1097/IAE.0000000000002002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。